布地奈德杂质D
|
|
|
- CAS号:
- 85234-63-5
- 英文名:
- 21-Dehydro Budesonide
- 英文别名:
- 21-Dehydro Budesonide;Budesonide IMpurity D;Budesonide EP Impurity D;Budesonide EP Impurity D (Mixture of Epimer);Budesonide Impurity 4(Budesonide EP Impurity D);"Budesonide impurity D" 21 dehydrogenated budesonide“;Budesonide EP Impurity-D (Budesonide Aldehyde Impurity);16α,17-[(1RS)-butylidenebis(oxy)]-11β-hydroxy-3,20-dioxopregna-1,4-dien-21-al;16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-3,20-dioxopregna-1,4-dien-21-al;(11β,16α)-16,17-[Butylidenebis(oxy)]-11-hydroxy-3,20-dioxopregna-1,4-dien-21-al
- 中文名:
- 布地奈德杂质D
- 中文别名:
- 布地奈德D;布地奈德杂质D;布地奈德杂质04;丁地去炎松杂质D;21-脱氢布地奈德;布地奈德EP杂质D;21-去氢布地奈德;布地奈德EP-ZD;布地奈德杂质对照品D;布地奈德杂质D(EP)
- CBNumber:
- CB12557990
- 分子式:
- C25H32O6
- 分子量:
- 428.52
- MOL File:
- 85234-63-5.mol
|
|
|
布地奈德杂质D化学性质
-
熔点:
-
>110oC (dec.)
-
|
-
沸点:
-
572.5±50.0 °C(Predicted)
-
|
-
密度:
-
1.27±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Hygroscopic, -20°C Freezer, Under inert atmosphere
-
|
-
溶解度:
-
DMSO (Slightly), Methanol (Slightly)
-
|
-
酸度系数(pKa):
-
14.21±0.70(Predicted)
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
White to Light Yellow
-
|
-
稳定性:
-
Hygroscopic
-
|
-
CAS 数据库:
-
85234-63-5
-
|
布地奈德杂质D性质、用途与生产工艺
布地奈德为局部应用的不含卤素的肾上腺皮质激素类药物。临床研究证明吸入本品具有与倍氯米松相似的局部抗炎作用，而无全身肾上腺皮质激素作用。用于非激素依赖性或激素依赖性哮喘和哮喘性慢性支气管炎患者，可有效地减少口服肾上腺皮质激素的副作用。布地奈德杂质D为布地奈德制备过程中产生的杂质。
布地奈德杂质D
上下游产品信息
上游原料
下游产品
85234-63-5, 布地奈德杂质D 相关搜索:
- Steroids
- Pharmaceuticals
- Metabolites & Impurities
- Intermediates & Fine Chemicals
- Impurities
- 标准品
- 对照品-杂质对照品
- 杂质对照品
- 159-布地奈德
- 布地奈德EP杂质D(差向异构体混合物)
- 布地奈德EP-ZD
- 21-去氢布地奈德
- 布地奈德杂质4(布地奈德EP杂质D)
- 布地奈德EP杂质D(异构体混合物)
- 布地奈德D
- 布地奈德EP杂质D(非对应异构体混合物)
- 布地奈德EP杂质D
- 布地奈德杂质D(EP)
- 布地奈德杂质对照品D
- 布地奈德杂质04
- 丁地去炎松杂质D
- 布地奈德杂质D 21-脱氢布地奈德"
- 布地奈德EP杂质D非对映体混合物
- 布地奈德杂质D
- 21-脱氢布地奈德
- 85234-63-5
- Budesonide EP Impurity D (Mixture of Epimer)
- 16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-3,20-dioxopregna-1,4-dien-21-al
- 2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a-dimethyl-4-oxo-10-propyl-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoacetaldehyde
- Budesonide EP Impurity-D (Budesonide Aldehyde Impurity)
- "Budesonide impurity D" 21 dehydrogenated budesonide“
- 2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a-dimethyl-4-oxo-10-propyl-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoacetaldehyde
- Pregna-1,4-dien-21-al, 16,17-[butylidenebis(oxy)]-11-hydroxy-3,20-dioxo-, (11β,16α)-
- Budesonide EP Impurity D
- Budesonide Impurity 4(Budesonide EP Impurity D)
- 16α,17-[(1RS)-butylidenebis(oxy)]-11β-hydroxy-3,20-dioxopregna-1,4-dien-21-al
- Budesonide IMpurity D
- (11β,16α)-16,17-[Butylidenebis(oxy)]-11-hydroxy-3,20-dioxopregna-1,4-dien-21-al
- 21-Dehydro Budesonide